Cystic Fibrosis

Cystic fibrosis (CF) is the most common, fatal genetic disease affecting young Canadians. Cystic fibrosis mainly affects people's lungs and digestion

Help To Fund Research Donate

$277,555
total amount funded

7
# of projects funded

View All Projects

All Projects 

Applicant Title Institution Province Amount Awarded
Yamashita, Cory Antimicrobial Peptide Fortified Surfactant for the Treatment of Cystic Fibrosis The University of Western Ontario Ontario $25,000
Speert, David Burkholderia cepacia complex bacteria in lung infections in cystic fibrosis: understanding the contribution of bacterial exopolysaccharide production to disease severity. University of British Columbia British Columbia $60,000
Quon, Bradley Discovery of Blood Protein Biomarkers to Monitor Treatment Responses during CF Pulmonary Exacerbations UBC – James Hogg Research Centre British Columbia $45,000
Quon, Bradley Identification of Novel Blood Biomarkers to Predict Pulmonary Exacerbations in Cystic Fibrosis. UBC James Hogg Research Centre British Columbia $50,000
Quon, Bradley Identification of novel plasma biomarkers to predict treatment response in acute exacerbations of cystic fibrosis University of British Columbia British Columbia $45,000
MacDonald, Marilyn Medication Adherence as a Safety Issue: Generating Theory from the Perceptions of Adults with Cystic Fibrosis, Families, and Healthcare Providers on the Medication Management Process Dalhousie University Nova Scotia $10,555
Trinh, Nguyen Understanding CFTR function in bronchial repair and improvement of epithelial regeneration by CFTR rescue Centre de Recherche du CHUM Quebec $42,000